CML is not hereditary and does not run in families. Although doctors perform genetic tests to diagnose it, these tests do not look for the kinds of genetic changes people can pass from parent to ...

The investigators examined the records of 2857 patients with Ph+ CML diagnosed from 2000 to 2019. Their median age fell between 55 and 59 years of age, with 57% younger than age 60, 20% between ...

Danziten is a twice daily, oral medication that inhibits the BCR-ABL tyrosine kinase. The FDA has approved Danziten™, a nilotinib formulation with no mealtime restrictions, for the treatment of ...

Chronic myeloid leukaemia (CML) is a type of blood cancer. It affects the blood and bone marrow. It tends to develop very slowly. There are different types of leukaemia and the treatment you need ...

Dr Lindsay Rein highlights how new CML data bring important considerations for clinical practice, patient tolerance, and the impact of treatment costs on quality of life.

A recent case report highlights an 82-year-old man with a long history of chronic lymphocytic leukemia (CLL) who was subsequently diagnosed with secondary chronic myeloid leukemia (CML). CLL and ...

Various symptoms indicate that CML has progressed. These include an increase in leukemia cells, a change in a person’s platelet count, and worsening anemia.

Doctors use molecular responses to monitor the effectiveness of CML treatment. A major molecular response is when the amount of the abnormal BCR–ABL gene in your blood and bone marrow is lowered ...

In May 2024, CML piloted the notary program at five locations. More than 500 customers used the free notary services at a library branch in 2024.

Focusing on the initiation of treatment for newly diagnosed patients with CML, Jorge E. Cortes, MD, details important factors to consider when starting treatment and Claire Saxton discusses strategies ...

Survival (prognosis) for chronic myeloid leukaemia (CML) depends on several factors such as age. No one can tell you exactly how long you will live. CML is usually a slowly developing condition and ...